Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

57
Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
57

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Progressive Aortic Regurgitation After Impella Bridge-to-LVAD: A Two-Year Cohort Analysis.

Biomedicines·2026
Same author

Development and Validation of an Acute Large Animal Model for Type A Aortic Dissection.

Journal of cardiovascular development and disease·2025
Same author

Challenging the Paradigm: Long-Term Outcomes in Dialysis-Dependent Patients Undergoing CABG.

Journal of cardiovascular development and disease·2025
Same author

Validity and Accuracy of the Derived Left Ventricular End-Diastolic Pressure in Impella 5.5.

Circulation. Heart failure·2025
Same author

Comparative Analysis of Liposuction and Conservative Treatment in Lipedema Patients: A Modified Body-Q Questionnaire Study.

Journal of clinical medicine·2025
Same author

Inflammatory and Hemolytic Responses of Microaxial Flow Pump Temporary Ventricular Assist Devices via Axillary Access in Cardiogenic Shock.

Medicina (Kaunas, Lithuania)·2025

Related Experiment Video

Updated: Jul 21, 2025

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
07:39

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Published on: August 16, 2021

3.7K

Hemoadsorption in LVAD Surgery: Suitable in Theory?

Mahmut Ozturk1, Aron Frederik Popov2

  • 1Division of Cardiac Surgery, Children's National Hospital, School of Medicine and Health Sciences, The George Washington University, Washington, DC 20010, USA.

Journal of Cardiovascular Development and Disease
|July 28, 2023
PubMed
Summary

Heart failure incidence is rising, driven by medical therapy advancements. This trend highlights the need for ongoing research into effective heart failure management strategies.

More Related Videos

Porcine Liver Transplantation Without Veno-Venous Bypass As an Extended Criteria Donor Model
12:49

Porcine Liver Transplantation Without Veno-Venous Bypass As an Extended Criteria Donor Model

Published on: August 17, 2022

2.5K
Implantation of the Syncardia Total Artificial Heart
16:11

Implantation of the Syncardia Total Artificial Heart

Published on: July 18, 2014

35.3K

Related Experiment Videos

Last Updated: Jul 21, 2025

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
07:39

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Published on: August 16, 2021

3.7K
Porcine Liver Transplantation Without Veno-Venous Bypass As an Extended Criteria Donor Model
12:49

Porcine Liver Transplantation Without Veno-Venous Bypass As an Extended Criteria Donor Model

Published on: August 17, 2022

2.5K
Implantation of the Syncardia Total Artificial Heart
16:11

Implantation of the Syncardia Total Artificial Heart

Published on: July 18, 2014

35.3K

Area of Science:

  • Cardiology and Internal Medicine
  • Clinical Research

Background:

  • The increasing prevalence of heart failure (HF) presents a significant global health challenge.
  • Advancements in medical therapies have improved patient survival but may contribute to a growing HF population.

Discussion:

  • Exploring the complex interplay between therapeutic progress and rising HF incidence.
  • Analyzing the long-term implications of current treatment paradigms on patient populations.
  • Identifying potential gaps in current management strategies for heart failure.

Key Insights:

  • Medical advancements, while beneficial, are associated with a growing number of heart failure patients.
  • The evolving landscape of heart failure necessitates a re-evaluation of treatment efficacy and long-term outcomes.
  • Understanding the drivers of increasing HF incidence is crucial for public health planning.

Outlook:

  • Future research should focus on preventative measures and innovative treatments for heart failure.
  • Developing sustainable healthcare models to manage the escalating burden of heart failure.
  • Investigating the impact of personalized medicine on heart failure management and patient prognosis.